Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Apr;71(4):935–949. doi: 10.1172/JCI110848

Ether Link Cleavage Is the Major Pathway of Iodothyronine Metabolism in the Phagocytosing Human Leukocyte and also Occurs In Vivo in the Rat

Albert G Burger 1, Dennis Engler 1, Ulrich Buergi 1, Michael Weissel 1, Gertraud Steiger 1, Sidney H Ingbar 2, Richard E Rosin 3,4, Bernard M Babior 3,4
PMCID: PMC436951  PMID: 6833495

Abstract

These studies were performed to test the hypothesis that ether link cleavage (ELC) is an important pathway for the metabolism of thyroxine (T4) in the phagocytosing human leukocyte. When tyrosyl ring-labeled [125I]T4([Tyr125I]T4) was incubated with phagocytosing leukocytes, 50% of the degraded label was converted into [125I]3,5-diiodotyrosine ([125I]DIT). Of the remaining [Tyr125I]T4 that was degraded, two-thirds was recovered as [125I]-nonextractable iodine ([125I]NEI), and one-third as [125I]iodide. The production of [125I]DIT was not observed when phenolic ring-labeled [125I]T4 ([Phen125I]T4) was used, although [125I]NEI and [125I]iodide were produced. None of these iodinated compounds were formed in leukocytes that were not carrying out phagocytosis.

The fraction of T4 degraded by ELC was decreased by the addition of unlabeled T4 and by preheating the leukocytes, findings which suggested that the process was enzymic in nature. ELC was enhanced by the catalase inhibitor aminotriazole, and was inhibited by the peroxidase inhibitor propylthiouracil, suggesting that the enzyme is a peroxidase and that hydrogen peroxide (H2O2) is a necessary cofactor in the reaction. To test this hypothesis, studies were performed in several inherited leukocytic disorders. ELC was not observed in the leukocytes of patients with chronic granulomatous disease, in which the respiratory burst that accompanies phagocytosis is absent. ELC was normal in the leukocytes of two subjects homozygous for Swiss-type acatalasemia, and aminotriazole enhanced ELC in these cells to an extent not significantly different from that observed in normal cells. ELC was normal in the leukocytes of a patient with myeloperoxidase deficiency, but could be induced by the incubation of [Tyr125I]T4 with H2O2 and horseradish peroxidase in the absence of leukocytes.

The in vivo occurrence of ELC in the rat was confirmed by demonstrating the appearance of [125I]DIT in serum from parenterally injected [125I]3,5-diiodothyronine, but no [125I]DIT was produced when [125I]3′,5′-diiodothyronine was administered.

From these findings we conclude the following: (a) ELC is the major pathway for the degradation of T4 during leukocyte phagocytosis, and accounts for 50% of the disposal of this iodothyronine; (b) the NEI and iodide formed by phagocytosing cells are derived from the degradation of the phenolic and tyrosyl rings of T4, although ELC per se accounts for only a small fraction of these iodinated products; (c) the process by which ELC occurs is enzymic in nature, and its occurrence requires the presence of the respiratory burst that accompanies phagocytosis; (d) the enzyme responsible for ELC is likely to be a peroxidase, although a clear role for myeloperoxidase as the candidate enzyme remains to be established; (e) iodothyronines are also degraded by ELC in vivo, and the quantitative importance of this pathway in various pathophysiological states requires further investigation.

Full text

PDF
935

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERENDES H., BRIDGES R. A., GOOD R. A. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–312. [PubMed] [Google Scholar]
  2. Babior B. M., Curnutte J. T., McMurrich B. J. The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J Clin Invest. 1976 Oct;58(4):989–996. doi: 10.1172/JCI108553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Babior B. M. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med. 1978 Mar 23;298(12):659–668. doi: 10.1056/NEJM197803232981205. [DOI] [PubMed] [Google Scholar]
  4. Baehner R. L., Nathan D. G. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science. 1967 Feb 17;155(3764):835–836. doi: 10.1126/science.155.3764.835. [DOI] [PubMed] [Google Scholar]
  5. Bellabarba D., Peterson R. E., Sterling K. An improved method for chromatography of iodothyronines. J Clin Endocrinol Metab. 1968 Feb;28(2):305–307. doi: 10.1210/jcem-28-2-305. [DOI] [PubMed] [Google Scholar]
  6. Björkstén F. The peroxidase-catalyzed oxidation of thyroxine. Acta Chem Scand. 1966;20(5):1438–1439. doi: 10.3891/acta.chem.scand.20-1438. [DOI] [PubMed] [Google Scholar]
  7. Burger A., Ingbar S. H. Labeling of thyroid hormones and their derivatives. Endocrinology. 1974 Apr;94(4):1189–1192. doi: 10.1210/endo-94-4-1189. [DOI] [PubMed] [Google Scholar]
  8. Chopra I. J. An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man. J Clin Invest. 1976 Jul;58(1):32–40. doi: 10.1172/JCI108456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chopra I. J., Solomon D. H., Chopra U., Wu S. Y., Fisher D. A., Nakamura Y. Pathways of metabolism of thyroid hormones. Recent Prog Horm Res. 1978;34:521–567. doi: 10.1016/b978-0-12-571134-0.50018-1. [DOI] [PubMed] [Google Scholar]
  10. Curnutte J. T., Whitten D. M., Babior B. M. Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med. 1974 Mar 14;290(11):593–597. doi: 10.1056/NEJM197403142901104. [DOI] [PubMed] [Google Scholar]
  11. DeRubertis F. R., Woeber K. A. Evidence for enhanced cellular uptake and binding of thyroxine in vivo during acute infection with Diplococcus pneumoniae. J Clin Invest. 1972 Apr;51(4):788–795. doi: 10.1172/JCI106873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dewald B., Baggiolini M., Curnutte J. T., Babior B. M. Subcellular localization of the superoxide-forming enzyme in human neutrophils. J Clin Invest. 1979 Jan;63(1):21–29. doi: 10.1172/JCI109273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dratman M. B., Richter M. E., Lynch H. A. Incorporation of thyroxin carbon in protein fractions of Rana catesbiana tadpole nervous system, liver and tail. Endocrinology. 1970 Feb;86(2):217–224. doi: 10.1210/endo-86-2-217. [DOI] [PubMed] [Google Scholar]
  14. GALTON V. A., INGBAR S. H. The mechanism of protein iodination during the metabolism of thyroid hormones by peripheral tissues. Endocrinology. 1961 Jul;69:30–38. doi: 10.1210/endo-69-1-30. [DOI] [PubMed] [Google Scholar]
  15. Gavin L., Castle J., McMahon F., Martin P., Hammond M., Cavalieri R. R. Extrathyroidal conversion of thyroxine to 3,3',5'-triiodothyronine (reverse-T3) and to 3,5,3'-triiodothyronine (T3) in humans. J Clin Endocrinol Metab. 1977 Apr;44(4):733–742. doi: 10.1210/jcem-44-4-733. [DOI] [PubMed] [Google Scholar]
  16. Goldstein I. M., Cerqueira M., Lind S., Kaplan H. B. Evidence that the superoxide-generating system of human leukocytes is associated with the cell surface. J Clin Invest. 1977 Feb;59(2):249–254. doi: 10.1172/JCI108635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gregerman R. I., Solomon N. Acceleration of thyroxine and triiodothyronine turnover during bacterial pulmonary infections and fever: implications for the functional state of the thyroid during stress and in senescence. J Clin Endocrinol Metab. 1967 Jan;27(1):93–105. doi: 10.1210/jcem-27-1-93. [DOI] [PubMed] [Google Scholar]
  18. Johnston R. B., Jr, Keele B. B., Jr, Misra H. P., Lehmeyer J. E., Webb L. S., Baehner R. L., RaJagopalan K. V. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest. 1975 Jun;55(6):1357–1372. doi: 10.1172/JCI108055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kaptein E. M., Robinson W. J., Grieb D. A., Nicoloff J. T. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis. J Clin Invest. 1982 Mar;69(3):526–535. doi: 10.1172/JCI110478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Klebanoff S. J., Green W. L. Degradation of thyroid hormones by phagocytosing human leukocytes. J Clin Invest. 1973 Jan;52(1):60–72. doi: 10.1172/JCI107174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Klebanoff S. J. Iodination of bacteria: a bactericidal mechanism. J Exp Med. 1967 Dec 1;126(6):1063–1078. doi: 10.1084/jem.126.6.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klebanoff S. J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol. 1968 Jun;95(6):2131–2138. doi: 10.1128/jb.95.6.2131-2138.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Klebanoff S. J., White L. R. Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N Engl J Med. 1969 Feb 27;280(9):460–466. doi: 10.1056/NEJM196902272800902. [DOI] [PubMed] [Google Scholar]
  24. Lutz J. H., Gregerman R. I., Spaulding S. W., Hornick R. B., Dawkins A. T., Jr Thyroxine binding proteins, free thyroxine and thyroxine turnover interrelationships during acute infectious illness in man. J Clin Endocrinol Metab. 1972 Aug;35(2):230–249. doi: 10.1210/jcem-35-2-230. [DOI] [PubMed] [Google Scholar]
  25. MAYRARGUE-KODJA A., BOUCHILLOUX S., LISSITZKY S. Action d'une peroxydase végétale sur divers amino-acides phénoliques: tyrosine, thyronine, et certains de leurs dérivés iodés ou hydroxylés. Bull Soc Chim Biol (Paris) 1958;40(5-6):815–831. [PubMed] [Google Scholar]
  26. Nakagawa S., Ruegamer W. R. Properties of a rat tissue iodothyronine deiodinase and its natural inhibitor. Biochemistry. 1967 May;6(5):1249–1261. doi: 10.1021/bi00857a005. [DOI] [PubMed] [Google Scholar]
  27. Nomura S., Pittman C. S., Chambers J. B., Jr, Buck M. W., Shimizu T. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest. 1975 Sep;56(3):643–652. doi: 10.1172/JCI108134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. PLASKETT L. G. Studies on the degradation of thyroid hormones in vitro with compounds labelled in either ring. Biochem J. 1961 Mar;78:652–657. doi: 10.1042/bj0780652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pincus S. H., Klebanoff S. J. Quantitative leukocyte iodination. N Engl J Med. 1971 Apr 8;284(14):744–750. doi: 10.1056/NEJM197104082841402. [DOI] [PubMed] [Google Scholar]
  30. Pittman C. S., Chambers J. B., Jr The carbon structure of thyroxine metabolites in urine. Endocrinology. 1969 Apr;84(4):705–710. doi: 10.1210/endo-84-4-705. [DOI] [PubMed] [Google Scholar]
  31. ROCHE J., NUNEZ J., JACQUEMIN C. [Nature of the deiodination products of thyroid hormones labelled simultaneously with tritium and radioactive iodiine]. Biochim Biophys Acta. 1962 Nov 5;64:475–486. doi: 10.1016/0006-3002(62)90305-0. [DOI] [PubMed] [Google Scholar]
  32. Reed P. W. Glutathione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes. J Biol Chem. 1969 May 10;244(9):2459–2464. [PubMed] [Google Scholar]
  33. Roos D., Weening R. S., Voetman A. A., van Schaik M. L., Bot A. A., Meerhof L. J., Loos J. A. Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood. 1979 May;53(5):851–866. [PubMed] [Google Scholar]
  34. Roos D., Weening R. S., Wyss S. R., Aebi H. E. Protection of human neutrophils by endogenous catalase: studies with cells from catalase-deficient individuals. J Clin Invest. 1980 Jun;65(6):1515–1522. doi: 10.1172/JCI109817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Root R. K., Metcalf J. A. H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest. 1977 Dec;60(6):1266–1279. doi: 10.1172/JCI108886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. SIEGEL E., SACHS B. A. IN VITRO LEUKOCYTE UPTAKE OF 131-I LABELED IODIDE, THYROXINE AND TRIIODOTHYRONINE, AND ITS RELATION TO THYROID FUNCTION. J Clin Endocrinol Metab. 1964 Apr;24:313–318. doi: 10.1210/jcem-24-4-313. [DOI] [PubMed] [Google Scholar]
  37. STERLING K., CHODOS R. B. Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease. J Clin Invest. 1956 Jul;35(7):806–813. doi: 10.1172/JCI103333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sorimachi K., Cahnmann H. J. A simple synthesis of [3,5-125I]Diiodo-L-thyroxine of high specific activity. Endocrinology. 1977 Oct;101(4):1276–1280. doi: 10.1210/endo-101-4-1276. [DOI] [PubMed] [Google Scholar]
  39. Sorimachi K., Ui N. Ion-exchange chromatographic analysis of iodothyronines. Anal Biochem. 1975 Jul;67(1):157–165. doi: 10.1016/0003-2697(75)90283-3. [DOI] [PubMed] [Google Scholar]
  40. Spielberg S. P., Boxer L. A., Oliver J. M., Allen J. M., Schulman J. D. Oxidative damage to neutrophils in glutathione synthetase deficiency. Br J Haematol. 1979 Jun;42(2):215–223. doi: 10.1111/j.1365-2141.1979.tb01126.x. [DOI] [PubMed] [Google Scholar]
  41. Surks M. I., Oppenheimer J. H. Composition of nonextractable radioactivity formed after injection of labeled L-thyroxine and 3,5,3'-triiodo-L-thyronine in rats. Endocrinology. 1970 Sep;87(3):567–575. doi: 10.1210/endo-87-3-567. [DOI] [PubMed] [Google Scholar]
  42. Surks M. I., Schwartz H. L., Oppenheimer J. H. Tissue iodoprotein formation during the peripheral metabolism of the thyroid hormones. J Clin Invest. 1969 Nov;48(11):2168–2175. doi: 10.1172/JCI106183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. TATA J. R. Transiodination of proteins during enzymic de-iodination of thyroxine. Nature. 1960 Sep 17;187:1025–1026. doi: 10.1038/1871025a0. [DOI] [PubMed] [Google Scholar]
  44. WYNN J., GIBBS R. Thyroxine degradation. II. Products of thyroxine degradation by rat liver microsomes. J Biol Chem. 1962 Nov;237:3499–3505. [PubMed] [Google Scholar]
  45. Wartofsky L., Martin D., Earll J. M. Alterations in thyroid iodine release and the peripheral metabolism of thyroxine during acute falciparum malaria in man. J Clin Invest. 1972 Sep;51(9):2215–2232. doi: 10.1172/JCI107030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Windhorst D. B., Page A. R., Holmes B., Quie P. G., Good R. A. The pattern of genetic transmission of the leukocyte defect in fatal granulomatous disease of childhood. J Clin Invest. 1968 May;47(5):1026–1034. doi: 10.1172/JCI105792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Woeber K. A. Alterations in thyroid hormone economy during acute infection with Diplococcus pneumoniae in the rhesus monkey. J Clin Invest. 1971 Feb;50(2):378–387. doi: 10.1172/JCI106505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Woeber K. A., Doherty G. F., Ingbar S. H. Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science. 1972 Jun 2;176(4038):1039–1041. doi: 10.1126/science.176.4038.1039. [DOI] [PubMed] [Google Scholar]
  49. Woeber K. A., Ingbar S. H. Metabolism of L-thyroxine by phagocytosing human leukocytes. J Clin Invest. 1973 Aug;52(8):1796–1803. doi: 10.1172/JCI107361. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES